Insights into September's Telehealth Usage Trends for 2024
Understanding September's Shift in Telehealth Utilization
In September 2024, a notable decline in telehealth utilization was observed across the nation, with decreases reported in every U.S. Census region. This shift follows a brief increase in usage during August, as highlighted by the Monthly Telehealth Regional Tracker. The national percentage of telehealth claim lines fell from 4.96% in August to 4.80% in September, marking a 3.3% decrease overall.
Regional Telehealth Claim Trends
The data paints a clear picture of how different regions are adapting. In the West, telehealth claim lines saw a decline of 5.4%. The South and Northeast experienced a dip of 1.5% each, while the Midwest recorded a 2.8% reduction. This comprehensive analysis specifically focuses on the commercially insured population, which notably excludes Medicare Fee-for-Service, Medicare Advantage, and Medicaid.
Shifts in Diagnostic Categories
An intriguing development in September was the entry of abnormal blood-pressure readings into the top five diagnostic categories for telehealth services in the West. This is the first time this year such a condition was recognized in the rankings, accounting for 1.5% of telehealth claim lines.
Nationwide, mental health conditions persisted as the primary diagnostic category for telehealth services. Acute respiratory diseases climbed from third to second place, whereas endocrine and metabolic disorders dropped from second to third. Developmental disorders fell to fifth place, overtaken by hypertension, which re-entered the rankings after a previous absence.
Demographics of Telehealth Usage
When examining telehealth claims by age group, those aged 19-30 and 31-40 represented the most substantial shares, both holding between 20% and 30% nationally and across regions. Notably, in the Midwest, the 19-30 age group achieved the largest share of telehealth claim lines for the first time since April, contributing 26.8% in both August and September. Conversely, the percentage of claims for the 31-40 age group slipped slightly from 26.9% to 26.7%.
Mental Health Trends
Throughout both August and September 2024, the top five mental health diagnoses showed stability. These included generalized anxiety disorder, major depressive disorder, adjustment disorders, attention-deficit/hyperactivity disorder, and post-traumatic stress disorder. Understanding these trends is essential for healthcare providers and policymakers as they navigate the evolving landscape of telehealth services.
Provider Specialties Ranking
Provider specialty rankings experienced some shifts as well. From August to September, the position of psychiatric nurse fell from third to fourth nationally, while psychiatrists moved up from fourth to third. In the South region, the rankings also saw a change with nurse practitioner dropping to fourth, while the psychiatric nurse climbed back to third.
Cost Dynamics in Telehealth Services
The Monthly Cost Spotlight presents some fascinating insights into telehealth services. In September, the median allowed amount for the CPT 90791 procedure was higher when delivered via telehealth compared to an office setting. A national average showed telehealth costing $141, compared to $135 for in-office consultations. In the Midwest, the differences were even more pronounced, with telehealth services averaging $142 against $138 for in-person visits.
Interestingly, the Northeast reported a reversal, where in-office costs of $152 surpassed the telehealth costs of $150, highlighting the variability and nuances of healthcare pricing across regions.
A Glimpse into Future Telehealth Trends
The Monthly Telehealth Regional Tracker, initiated as a free service in May 2020, serves as a vital resource for tracking changes in telehealth over time. By utilizing FAIR Health data, stakeholders can now access an interactive platform showcasing variations in telehealth utilization. It includes insights on diagnostic categories, age distribution, and comparative cost analyses, enhancing decision-making for healthcare strategies moving forward.
Frequently Asked Questions
What factors contributed to the decrease in telehealth utilization in September 2024?
The decline could be attributed to seasonal changes, varying patient needs, or a shift back to traditional in-person consultations after an initial increase in usage in August.
How did the telehealth claims vary by region?
Each Census region experienced a decrease in telehealth claims, with the West showing the largest decline at 5.4%, followed by Midwest and Northeast regions with smaller decreases.
What were the top mental health diagnoses this September?
The top mental health conditions remained unchanged, with generalized anxiety disorder and major depressive disorder leading national statistics.
How did age impact telehealth claim lines?
The age groups 19-30 and 31-40 consistently represented the largest shares of telehealth claim lines, with notable trends observed in the Midwest.
Where can I find more detailed telehealth utilization data?
For comprehensive insights and specific figures, the Monthly Telehealth Regional Tracker from FAIR Health is available as a free resource.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.